Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10034832 | 0.84 | TSHR (0.33) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL10034830 | 0.83 | TSHR (0.35) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL17530145 | 0.82 | TSHR (0.55) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL12604000 | 0.79 | SMN1; SMN2 (0.32) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL17640924 | 0.76 | SMN1; SMN2 (0.58) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL10034835 | 0.75 | TSHR (0.39) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL13196943 | 0.73 | — | — | |
| SCHEMBL12827070 | 0.73 | TSHR (0.41) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL12311054 | 0.73 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL19196927 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9786954-B2 | Electrolyte including silane for use in electrochemical devices | ORBIA FLUOR & ENERGY MATERIALS USA, INC. | 2017-10-10 | — | — | US | disclosed |
| US-20140342244-A1 | ELECTROLYTE INCLUDING SILANE FOR USE IN ELECTROCHEMICAL DEVICES | ORBIA FLUOR & ENERGY MATERIALS USA, INC. | 2014-11-20 | — | — | US | disclosed |
| US-8765295-B2 | Electrolyte including silane for use in electrochemical devices | WEST ROBERT C (US) | 2014-07-01 | — | — | US | disclosed |
| US-20120135313-A1 | ELECTROLYTE INCLUDING SILANE FOR USE IN ELECTROCHEMICAL DEVICES | WEST ROBERT C (US) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135313-A1 | ELECTROLYTE INCLUDING SILANE FOR USE IN ELECTROCHEMICAL DEVICES | HCN2, CLCN2, SCNN1A | TSHR 4161/4885SMN1; SMN2 3402/4885ALDH1A1 1754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.